News Releases

News & Resources

News Releases

ECCRT, a Synteract Company, Continues to Garner Recognition and Partners for Clinical Trials Training Courses

European Centre for Clinical Research Training recognized by Swiss Ethics Committees and partners with ACRP due to its high training standards

SAN DIEGO AND BRUSSELS – July 16, 2014 – The European Centre for Clinical Research Training (ECCRT), a Synteract company, has been recognized by the Swiss Association of Ethics Committees for Clinical Trials for delivering high quality GCP (Good Clinical Practice) and GCP refresher training for investigators and sub-investigators. In addition, the training center has been chosen by The Association of Clinical Research Professionals (ACRP) as a collaboration partner to develop and implement the “STAR Programme,” a comprehensive clinical research training and development program being offered across Europe.

The new ECCRT/ACRP STAR Programme is a 15-month training and professional development program that will ensure participating clinical researchers have the level of experience that employers desire in research staff as well as the requisite expertise to sit for ACRP Certification Exams. It combines intensive in-person training, access to the ACRP membership community, and robust eLearning modules in a defined program supported by on-the-job experience to deliver a comprehensive curriculum for clinical research coordinators, clinical research associates, or investigators.

“The combined expertise of ECCRT and ACRP has resulted in a program that is ideal for new clinical research professionals,” says ACRP Executive Director James Thomasell. “It provides the intensity needed to create a solid foundation as well as the longevity to ensure that essential topics are retained over time. The end result is a competent, confident and capable clinical researcher.”

The Swiss Ethics Committees (Swissethics) is an association of members who are the recognized regional/cantonal ethics committees of Switzerland and is focused on research involving humans. It has formed a joint working group mandated to facilitate: coordination and standardization of working processes; external representation towards Swissmedic, BAG, industry, GDK, SCTO, EURECNET; education and training of members of the ethics committees.

Gerald Van Roey, managing director of ECCRT, says, “Together with our previous commendations – including our Qfor label, our recent TransCelerate recognition, and approval by the Flemish and Walloon government of Belgium – this recognition by the Swiss Ethics Committees and our collaboration with ACRP shows our value as a center of excellence. Large professional organizations trust us and rely on our quality training to help people become even more professional. Our end goal is to provide a foundation that ideally results in both certification and high performing professionals.”

About Synteract 
Synteract is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Synteract has conducted Phase I-IV studies on six continents and in more than 50 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, Synteract provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

CONTACT:
Beth Walsh
beth@clearpointagency.com
760-230-2424

x

Contact Synteract

Tell us how to stay in touch with you:

*Required